SCHEMBL19873655

SCHEMBL19873655

COc1cc(-c2sc(Cl)cc2NC(=O)OC(C)c2cscc2C)ccc1-c1ccc(C2CC2)cc1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 1/20 0.31
TACR1 P25103 1/20 0.31
LPAR1 Q92633 1/20 0.31
LPAR3 Q9UBY5 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
MCHR1 Q99705 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
ENPP2 Q13822 2/20 0.30
NPC1 O15118 1/20 0.30
TGFBR1 P36897 1/20 0.30
ACVR1 Q04771 1/20 0.30
STAT3 P40763 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19873659 0.93 AKR1C3 (0.32) TACR2TACR1LPAR1LPAR3AAK1
SCHEMBL19873609 0.91 APP (0.32) LPAR1LPAR3MCHR1ALDH1A1KDM4E
SCHEMBL19873573 0.90 ROCK2 (0.34) LPAR1LPAR3ALDH1A1LMNAENPP2
SCHEMBL19873571 0.90 ROCK2 (0.34) LPAR1LPAR3ALDH1A1LMNAENPP2
SCHEMBL19873585 0.90 LPAR1 (0.34) LPAR1LPAR3KDM4EENPP2
SCHEMBL19873583 0.90 LPAR1 (0.34) LPAR1LPAR3KDM4EENPP2
SCHEMBL19873566 0.88 LPAR1 (0.36) LPAR1
SCHEMBL19873576 0.88 LPAR1 (0.36) LPAR1
SCHEMBL19873643 0.88 LPAR1 (0.41) LPAR1LPAR3ENPP2
SCHEMBL19873642 0.88 LPAR1 (0.41) LPAR1LPAR3ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3360869-B1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND USEFUL FOR THE TREATMENT OF DISEASES CAUSED BY LPA. UBE INDUSTRIES (JP) 2020-07-29 EP claimed
EP-2940013-B1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND UBE INDUSTRIES (JP) 2018-02-21 EP claimed